-
41.
公开(公告)号:US20190350912A1
公开(公告)日:2019-11-21
申请号:US16339042
申请日:2017-10-03
Inventor: Jian-Ting Zhang , Jian-Yuan Liu
IPC: A61K31/4439 , A61K31/502 , A61K31/454 , A61K31/137 , A61K31/5025 , A61K31/4184 , A61K31/55 , A61P35/00
Abstract: Various aspects and embodiments disclosed herein relate generally to the modelling, treatment, reduction of resistance to the treatment, prevention, and/or diagnosis of diseases characterized by the formation of cancers. Embodiments include methods of treating cancer, comprising the steps of: providing a patient diagnosed with cancer with a therapeutic regime that includes at least one therapeutically effective dose of at least one agent that reduces the activity of at least one DNA damage/repair pathway. Other embodiments include methods of treating cancer, comprising the steps of: treating a patient diagnosed with cancer with a combination of therapeutic agents that includes at least one therapeutically effective anti-cancer agent and at least one compound that reduces the activity of at least one DNA damage/repair pathway. Yet other embodiments include methods of reducing resistance to a genotoxic therapeutic, comprising the steps of: treating a patient at least one therapeutically effective dose of at least one agent that reduces at least one DNA damage/repair pathway.
-
公开(公告)号:US10465823B2
公开(公告)日:2019-11-05
申请号:US15519154
申请日:2015-10-21
Inventor: John Finnell , Jeff Quinn , Brad Wheeler
Abstract: An identifier for a conduit includes a first tag having a body with a first aperture formed therein for receiving the conduit and a first identifying feature, and a second tag having a body with a second aperture formed therein for receiving the conduit and a second identifying feature that matches the first identifying feature. The first tag is attached to the conduit adjacent one end, the second tag is attached to the conduit adjacent another end, and the ends are identified as ends of the same conduit by the matching first and second identifying features.
-
43.
公开(公告)号:US20190274988A1
公开(公告)日:2019-09-12
申请号:US16418276
申请日:2019-05-21
Inventor: Mark R. Kelley
IPC: A61K31/201 , A61K33/24 , A61K31/7068 , A61K31/198 , A61K31/454 , A61K31/203 , A61K31/122 , A61K45/06 , A61K31/282 , A61K31/195 , A61K31/13 , A61K39/395
Abstract: Disclosed are novel methods for the therapeutic treatment of cancer and angiogenesis. The enzyme Ape1/Ref-1, via its redox function, enhances the DNA binding activity of transcription factors that are associated with the progression of cancer. The present disclosure describes the use of agents to selectively inhibit the redox function of Ape1/Ref-1 and thereby reduce tumor cell growth, survival, migration and metastasis. In addition, Ape1/Ref-1 inhibitory activity is shown to augment the therapeutic effects of other therapeutics and protect normal cells against toxicity. Further, Ape1/Ref-1 inhibition is shown to decrease angiogenesis, for use in the treatment of cancer as well other pathologic conditions of which altered angiogenesis is a component.
-
公开(公告)号:US20190255055A1
公开(公告)日:2019-08-22
申请号:US16311533
申请日:2017-06-20
Applicant: The Regents of the University of Michigan , Indiana University Research and Technology Corporation
Inventor: Scott D. Larsen , Brandt C. Huddle , Kun Yang , Ronald Buckanovich , Thomas Hurley
IPC: A61K31/519 , A61P31/00 , A61P35/00 , A61K45/06 , C07D487/04
Abstract: This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a thiopyrimidinone structure which function as inhibitors of ALDH protein, and their use as therapeutics for the treatment of cancer and other diseases.
-
公开(公告)号:US10377748B2
公开(公告)日:2019-08-13
申请号:US15760284
申请日:2016-09-15
Inventor: William Turner , Lee Daniel Arnold , Hans Maag , Leping Li , Mark Bures , Simon Haydar , Samson Francis
IPC: C07D417/12 , A61P31/20 , C07D403/12 , A61K45/06 , C07D401/12 , C07D413/12 , C07D417/14 , C07D453/02 , C07D471/04 , C07D243/38 , C07D267/20 , C07D281/16
Abstract: The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
-
公开(公告)号:US10371638B2
公开(公告)日:2019-08-06
申请号:US15739152
申请日:2016-07-06
Inventor: Hany Osman
Abstract: The present disclosure provides a method and system including a non-confocal microscope with an attached imaging fiber optic for direct and real time visualization of mammalian microscopic structures for diagnostic and therapeutic uses.
-
公开(公告)号:US20190230478A1
公开(公告)日:2019-07-25
申请号:US16369928
申请日:2019-03-29
Inventor: Kylie Aine Peppler , Joshua A. Danish , Shenshen Han
Abstract: A real time tracking and positioning system comprising at least four anchors, at least one actor configured to interact with the at least four anchors, and an electronic device in communication with at least one of the at least four anchors, the electronic device being configured to receive two-way ranging/distance data for each actor and calculate a real-time position of each actor based on the two-way ranging/distance data, the two-way ranging/distance data including a round-trip time of a radio frequency signal between the at least one actor and each of the at least four anchors.
-
公开(公告)号:US20190218268A1
公开(公告)日:2019-07-18
申请号:US16098236
申请日:2017-05-31
Inventor: Richard D. DIMARCHI , John P. MAYER , Piotr MROZ
IPC: C07K14/605 , A61P3/10 , A61K38/26 , A61K38/28
Abstract: Modified glucagon peptides are disclosed having improved solubility and/or stability while retaining glucagon agonist activity. The glucagon peptides have been modified by the substitution of pyridyl-alanine for a native amino acid at one or more of positions 6, 10 or 13 and/or substitution with an amino acid in the D-conformation at position 20 or 21 compared to native glucagon.
-
49.
公开(公告)号:US20190214114A1
公开(公告)日:2019-07-11
申请号:US16330674
申请日:2017-09-06
Inventor: Titus Karl Ludwig Schleyer
CPC classification number: G16H10/20 , G06F16/335 , G06Q10/10 , G06Q50/10 , G06Q50/22 , G16H10/60 , G16H80/00
Abstract: Methods for generating a health management template for a patient condition including retrieving a healthcare template It corresponding to a patient condition, the healthcare template comprising a plurality of data fields, populating the data fields with patient data; and generating an updated healthcare template based on a user input, wherein the user input comprises at least one of a search request or a data option selection are disclosed. Systems are also disclosed.
-
公开(公告)号:US20190127433A1
公开(公告)日:2019-05-02
申请号:US16241932
申请日:2019-01-07
Inventor: Richard D. DiMARCHI , David L. SMILEY
IPC: C07K14/605 , A61K49/00 , A61K38/26 , G01N33/74 , A61K39/395 , C07K16/28 , A61K47/60
Abstract: Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.
-
-
-
-
-
-
-
-
-